Dr. Arnold-Paul C. Cua, MD

Dr. Cua practices at Providence Infusion and Pharmacy Services in Tukwila, Washington.

Dr. Cua's NPI, 1649243304, was assigned on February 10, 2006. Dr. Cua holds Washington license MD60514750.

Dr. Cua's primary practice is Providence Infusion and Pharmacy Services, at 3333 S 120th Pl, Tukwila, WA 98168 in King County. The practice phone is (425) 687-4400.

Dr. Cua's primary practice is Providence Infusion and Pharmacy Services in Tukwila, Washington. Dr. Cua is also affiliated with MultiCare Tacoma General Hospital. The medical group on file is MultiCare Indigo Urgent Care, Spokane, Newport Hwy. Dmand AI also links Dr. Cua to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cua practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Cua's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Cua's licenses on file in 2 states: Washington and Nevada.

CMS data shows 516 Medicare services from Dr. Cua across 6 procedure codes in 2024, for 105 Medicare patients. Medicare paid $42,852 for them.

CMS counts 105 Medicare patients who saw Dr. Cua in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cua's median patient age at 68, with 37% women.

In 2024, Dr. Cua wrote 483 Medicare Part D claims for 82 patients. 59% of them were for generic drugs. CMS names the drug for 376 of them, across 17 drugs with 11 or more claims each, at $590,531 in total drug cost. In 2023, CMS named 341 claims across 15 drugs.

Dr. Cua accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cua as offering telehealth.

CMS Open Payments shows 29 general payments to Dr. Cua from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 74% of the total. Astellas Pharma US Inc paid the most, $230.